Fluoxetine increases GABAA receptor activity through a novel modulatory site

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 3, 2003, Pages 978-984

  Robinson, Richard T ^a   Drafts, Brandon C ^a   Fisher, Janet L ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE DERIVATIVE; FLUOXETINE; NORFLUOXETINE; SEROTONIN UPTAKE INHIBITOR; ZINC;

ANIMAL CELL; ANTICONVULSANT ACTIVITY; ARTICLE; DEPRESSION; DRUG MECHANISM; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MOUSE; MUTATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FLUOXETINE; GAMMA-AMINOBUTYRIC ACID; MAMMALS; RECEPTORS, GABA-A; RECOMBINANT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 0037369851     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.044834     Document Type: Article

References (41)

1. A receptor subunits: analysis of transient single-cell expression utilizing a fluorescent substrate/marker gene technique. J Neurosci 13:1418-1428.
2. 3 receptor by nicotine, cocaine and fluoxetine investigated by rapid chemical kinetic techniques. Biochemistry 40:8419-8429.
3. Casula MA, Bromidge FA, Pillai GV, Wingrove PB, Martin K, Maubach K, Seabrook GR, Whiting PJ, and Hadingham KL (2001) Identification of amino acid residues responsible for the a5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABAA receptor. J Neurochem 77:445-451.
4. Chesnut JD, Baytan AR, Russell M, Chang M-P, Bernard A, Maxwell IH, and Hoeffler JP (1996) Selective isolation of transiently transfected cells from a mammalian cell population with vectors expressing a membrane anchored single-chain antibody. J Immunol Methods 193:17-27.
5. Choi BH, Choi J-S, Yoon SH, Rhie D-J, Min DS, Jo Y-H, Kim M-S, and Hahn SJ (2001) Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1. Neuropharmacology 41:443-453.
6. A receptor. J Neurosci 22:5572-5580.
7. Dailey JW, Yan QS, Mishra PK, Burger RL, and Jobe PC (1992) Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J Pharmacol Exp Ther 260:533-540.
8. Deák F, Lasztóczi B, Pacher P, Petheö GL, Kecskeméti V, and Spät A (2000) Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology 39:1029-1036.
9. 3 receptor-mediated current by the selective serotonin uptake inhibitor, fluoxetine, Neurosci Lett 173:210-212.
10. Favale E, Rubino V, Mainardi P, Lunardi G, and Albano C (1995) Anticonvulsant effect of fluoxetine in humans. Neurology 45:1926-1927.
11. A receptor activity by voltage. Mol and Cell Neurosci 20:683-694.
12. Fisher JL (2002b) A histidine residue in the extracellular N-terminal domain of the GABAA receptor α5 subunit regulates sensitivity to inhibition by zinc. Neuropharmacology 42:922-928.
13. A-receptors in temporal lobe epilepsy. Neurochem Int 34:435-445.
14. García-Colunga J, Awad JN, and Miledi R (1997) Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 94:2041-2044.
15. Griffin LD and Mellon SH (1999) Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA 96:13512-13517.
16. Greenfield LJ Jr, Sun F, Neelands TR, Burgard EC, Donnelly JL, and Macdonald RL (1997) Expression of functional GABAA receptors in the transfected L929 cells isolated by immunomagnetic bead separation. Neuropharmocology 36:63-73.
17. Houser CR and Esclapez M (1996) Vulnerability and plasticity of the GABA system in the pilocarpine model of spontaneous recurrent seizures. Epilepsy Res 26:207-218.
18. A receptors containing a5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: an extended ethanol reward circuitry. J Neurosci 21:2166-2177.
19. Karson CN, Newton JEO, Livingston R, Jolly JB, Cooper TB, Sprigg J, and Komoroski RA (1993) Human brain fluoxetine concentrations. J Neuropsychiatry Clin Neurosci 5:322-329.
20. A receptors. Prog Neurobiol 67:113-159.
21. A receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 12:4151-4172.
22. Leander JD (1992) Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine and ameltolide (LY201116). Epilepsia 33:573-576.
23. A receptors in tolerant rat brain indicates particular involvement of the hippocampal CA1 region. J Pharmacol Exp Ther 295:689-696.
24. A receptors. J Med Chem 39:1928-1934.
25. Maertens C, Wei L, Voets T, Droogmans G, and Nilius B (1999) Block by fluoxetine of volume-regulated anion channels. Br J Pharmacol 126:508-514.
26. A receptor complex based upon antagonist-induced encephalographic power spectrum changes. Neuropsychobiology 42: 149-157.
27. Möhler H, Fritschy JM, and Rudolph U (2002) A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300:2-8.
28. Orsulak PJ, Kenney JT, Debus JR, Crowley G, and Wittman PD (1988) Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection. Clin Chem 34:1875-1878.
29. Pasini A, Tortorella A, and Gale K (1992) Anticonvulsant effect of intranigral fluoxetine. Brain Res 593:287-290.
30. Pato MT, Murphy DL, and DeVane CL (1991) Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J Clin Psychopharmacol 11:224-225.
31. Prendiville S and Gale K (1993) Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia 34:381-384.
32. A receptors which contain the α5 subunit. Neuropharmacology 35:1331-1335.
33. Rice A, Rafiq A, Shapiro SM, Jakoi ER, Coulter DA, and DeLorenzo RJ (1996) Long-lasting reduction of inhibitory function and γ-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy. Proc Natl Acad Sci USA 93:9665-9669.
34. Rosenstein DL, Nelson JC, and Jacobs SC (1993) Seizures associated with antideqpressants: a review. J Clin Psychiatry 54:289-299.
35. Sanchez C and Hyttel J (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19:467-489.
36. A receptors. Mol Pharmacol 58:1434-1440.
37. Thomas D, Gut B, Wendt-Nordahl G, and Kiehn J (2002) The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. J Pharmacol Exp Ther 300:543-548.
38. Tunnicliff G, Schindler NL, Crites GJ, Goldenberg R, Yochum A, and Malatynska E (1999) The GABAA receptor complex as a target for fluoxetine action. Neurochem Res 24:1271-1276.
39. Tytgat J, Maertens C, and Daenens P (1997) Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1). Br J Pharmacol 122:1417-1424.
40. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, and Guidotti A (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 95:3239-3244.
41. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12:1040-1062.